A study on the effect of combining genetic test and plasma amino acid test on promoting health care actions.

A study on the effect of combining genetic test and plasma amino acid test on promoting health care actions. - A study on the effect of combining genetic test and plasma amino acid test on promoting health care actions.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022358

Enrollment

240

Registered

2016-05-20

Start date

2015-10-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic syndrome and cancer

Interventions

Questionaire survey -&gt

sampling of 5ml blood for amino acid measurement -&gt

Questionnaire survey -&gt

Sampling of saliva for SNP analysis -&gt

Questionnaire survey Questionnaire survey -&gt

sampling of saliva for SNP analysis -&gt

Sampling of 5ml blood for amino acid measurement -&gt

Questionnaire survey

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Persons who have submitted written informed consent

Exclusion criteria

Exclusion criteria: 1)Those who are pregnant, or breast feeding 2)Those who have congenital metabolic disorders 3)Those who are undergoing dialysis 4)Those who are participating in another clinical study 5)Those who have mental diseases or disorders and for whom doctors judged difficult to participate in the study. 6)Those for whom the doctor judged inappropriate to participate in the study.

Design outcomes

Primary

Measure	Time frame
Analysis on the promoting effect of either single test or combination of genetic test and plasma amino acid test on taking health care actions by questionnaire survey before and 1 month after either test.	—

Secondary

Measure	Time frame
Analysis on the promoting effect of the results of genetic and plasma amino acid test on taking health care actions by questionnaire survey before and 1 month after either test.	—

Countries

Japan

Contacts

Public ContactNahoko Shikata

Ajinomoto Co. INC. Institute for Innovation

nahoko_shikata01@ajinomoto.com044-210-5828

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026